Neuland Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

13891.15

-537.10 (-3.72%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

13891.15

-537.10 (-3.72%)
16:02 Dec 20

Quality

79/100
High Financial Strength

Valuation

15/100
Expensive Valuation

Technical

61/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	936.91	951.08	1191.2	1558.58	1528.28
Operating Expenses +	790.09	808.45	919.35	1095.99	1114.51
Raw Material	439.66	437.55	487.74	632.43	616.55
Increase Decrease in Cost	-1.24	-15.41	-9.51	-55.14	-42.46
Other Manufacturing Expense	120.29	131.36	135.56	156.51	0
Employee Cost	149.74	182.47	201.79	257.06	264.43
Miscellaneous Expenses	81.64	72.48	103.77	105.13	275.99
Operating Profit	146.82	142.63	271.85	462.59	413.77
Other Income	16.1	2.08	9.75	12.54	16.6
Depreciation	39.68	49.04	52.78	59.7	63.95
Interest	17.9	13.5	13.07	14	11.08
Profit before tax and exceptio..	105.33	82.16	215.75	401.44	355.34
Exceptional Items	0	0	0	0	20.63
PBT	105.33	82.16	215.75	401.44	334.71
Provision for Taxation	24.7	18.34	52.23	101.36	96.28
Net Profit	80.63	63.82	163.52	300.08	279.66
NET Profit after MI	80.63	63.82	163.52	300.08	279.66
EPS	62.85	49.74	127.45	233.89	217.98
Operating Profit Margin (%)	15.67	15	22.82	29.68	27.07
Net Profit Margin (%)	8.61	6.71	13.73	19.25	18.3

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	32.60	32.70	32.70	32.80	36.00
FII	26.50	25.70	24.40	22.70	21.60
MF	4.00	4.10	3.90	1.80	1.90
Public	34.10	34.80	35.90	38.10	35.10
Others	0.10	0.00	0.00	0.00	0.00
Others	2.70	2.70	3.10	4.60	5.40